AssetMark’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
AssetMark's AMPH Position: Q3 2026 in Review
AssetMark increased its Amphastar Pharmaceuticals (AMPH) stake by 15% in Q3 2026, buying an estimated $228K and bringing the position to 79,124 shares worth $2.04M. The position accounts for ﹤0.01% of the portfolio, ranked #946.
AssetMark first reported a position in AMPH in Q4 2016 and has held it in 19 quarters since. The position peaked at $2.21M in Q4 2023. 175 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- AssetMark held 79,124 shares of Amphastar Pharmaceuticals worth $2.04M as of Q3 2026.
- AssetMark bought 10,534 Amphastar Pharmaceuticals shares in Q3 2026, an estimated $228K.
- Amphastar Pharmaceuticals made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #946 holding.
- AssetMark first reported a position in Amphastar Pharmaceuticals in Q4 2016 and has held it in 19 quarters since.
- AssetMark's Amphastar Pharmaceuticals position peaked at $2.21M in Q4 2023.
- 175 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.